Latest filing published 26 Jan 2017 for OSIRIS THERAPEUTICS, INC., €24k.
This profile gathers the share dealings of David A. Dresner in Osiris Therapeutics, Inc. Over a trading history stretching from 12 January 2017 to 25 January 2017, the count stands at 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 26 January 2017 with an option exercise (€24k) in Osiris Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations